Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations

INTRODUCTION: This phase I study explored the immunogenicity and reactogenicity of accelerated, Q7 fractional, intradermal vaccination regimens for COVID-19. METHODS: Participants (n = 60) aged 18-60 years, naïve to SARS-CoV-2 infection or vaccination, were randomly allocated into one of four homolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Niyomnaitham, Suvimol, Atakulreka, Suparat, Wongprompitak, Patimaporn, Copeland, Katherine Kradangna, Toh, Zheng Quan, Licciardi, Paul V., Srisutthisamphan, Kanjana, Jansarikit, Laddawan, Chokephaibulkit, Kulkanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886662/
https://www.ncbi.nlm.nih.gov/pubmed/36733395
http://dx.doi.org/10.3389/fimmu.2022.1080791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886662/
https://www.ncbi.nlm.nih.gov/pubmed/36733395
http://dx.doi.org/10.3389/fimmu.2022.1080791

Ejemplares similares